Researchers receive £2.4 million to generate evidence on the new NHS Pharmacy First service

NewsGuard 100/100 Score

Researchers from the London School of Hygiene & Tropical Medicine (LSHTM) have been awarded £2.4m by the National Institute for Health and Care Research (NIHR) to generate evidence on the new National Health Service (NHS) Pharmacy First service.

The service launched across England in January 2024 under the Government's NHS Primary Care Recovery Plan. From February 2024, participating pharmacies will be able to supply prescription-only medicines for seven common conditions: earache, uncomplicated urinary tract infections in women, sore throat, sinusitis, impetigo, shingles and infected insect bites, after consultation with a community pharmacist. 

The research team will work in partnership with experts at the UK Health Security Agency (UKHSA) and the Universities of Oxford, Manchester, and Nottingham, to evaluate Pharmacy First's take-up, safety, equity, cost-effectiveness and acceptability, as well as its implications for antibiotic use and antimicrobial resistance.

I am delighted to lead this complex three-year Pharmacy First evaluation, where we will evaluate Pharmacy First's impact on GPs and the wider NHS, pharmacy services and patients.

Our team has expertise in evaluating complex policy interventions, such as the last two UK Antimicrobial Resistance National Action Plans, so alongside expert external colleagues, we will pay particular attention to the impact of Pharmacy First on antibiotic prescribing and resistance across the health system."

Dr Rebecca Glover, Project Lead, Assistant Professor in Antimicrobial Resistance at LSHTM

Throughout the evaluation, the research teams will work closely with co-researchers who are from historically marginalized-in-research and medically-underserved communities. Their analysis will contribute to understanding of potential consequences of Pharmacy First for inequalities in access to health services and outcomes.

At LSHTM, Dr Glover will jointly lead the project with Professor Nicholas Mays, working alongside Drs Mirza Lalani, Agata Pacho, and Stephen O'Neill.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Pioneering vaccine strategy promises to outmaneuver antimicrobial resistance